Neutral impactStocks

Sun Pharma Q2 Results: US sales meet expectations; Other parameters deliver a beat

CNBC-TV18 49 min ago·30 Oct 2026, 8:57 am

While Sun Pharma's margins narrowed from the same quarter last year, they turned out to be better than what the street had feared, as did India's largest drugmakers' revenue and EBITDA.

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Sun Pharmaceutical Industries (SUNPHARMA).
  • Category: Stocks.

Why it matters

A routine update for Sun Pharmaceutical Industries. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.

More Stocks news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.